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a–d TurkeyIntroduction: In selected cases with thoracic aortic aneurysm (TAA), thoracic endovascular aortic replacement
(TEVAR) is commonly used and shall be proper therapy method. We are presenting a case of TAA previously treated
twice by endovascular aortic approaches and complicated by type 1 endoleak.
Case: A 67-year-old male patient was admitted to our clinic with back pain at rest. He underwent TEVAR five
years ago, twice in 6 month. With contrasted computed tomography of chest and abdomen, a new type 1 proximal
endoleak was diagnosed, and after routine preoperative follow up, the patient was operated on. At the same session
right to left caroticocarotid bypass and re-redo TEVAR were performed. The new endovascular graft was placed as
the proximal landing zone to be set between left carotid artery and brachiocephalic truncus. The patient was dis-
charged on postoperative day 4 without any problems.
Conclusion: As new techniques and methods have been developed, mortality rates have decreased to 2–3% but in
older and high risk patients, mortality rates still remain high [1]. TEVAR is a safe and effective treatment method in
the proper and selected patients with thoracic artery aneurysm [2]. Moreover, TEVAR can also be performed as a part
of hybrid procedures for arcus aortic aneurysms [3]. But it should be kept in mind that late secondary intervention
rates are higher in TEVAR.
 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.
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Thoracic aortic aneurysm (TAA) has alwaysbeen one of the most complicated topics of
cardiovascular surgery. The open surgery is not
easy to perform and also the recovery period is
long and vulnerable both for the surgeon and
the patient. Moreover, open surgery has high a
mortality and morbidity ratio especially in high
risk, older patients and in patients with aortic arc
involvement.
We are presenting a case of TAA – previously
treated twice by TEVAR – with type 1 proximal
endoleak.Figure 2. Angiography sight before the new stent graft placement.
Caroticocarotid bypass on the upper part of the figure; old stent graft
on the right left part of the figure.Case
A 67-year-old male patient was admitted to our
clinic with back pain at rest with a history of two
operations for aortic aneurysm. Five years previ-
ously he underwent TEVAR in our institution for
descending thoracic aortic aneurysm with Stan-
ford Type B dissection (40 No. 20 cm Medtronic
Talent Graft). In that procedure, proximal landing
zone (PLZ) was kept between left carotid artery
(LCA) and left subclavian artery (LSA). Six
months after the operation for type 1 distal leak,
he underwent a second TEVAR procedure in an-
other institution. Five years’ follow up have been
uneventful.Figure 1. (a) and (b) Preoperative contrasted computed tomography.
Figure 3. Postoperative contrasted computed tomography of the chest
and the neck.In the latest admission, physical examination
was normal; all peripheral pulses were palpable
except the left upper extremity. In contrasted
computed tomography (CT) (Fig. 1), the ascending
aorta was 42 mm wide. Type 1 leak from the prox-
imal edge was seen. After routine preoperative
follow-up, the operation was scheduled.
Before the endovascular procedure, right to left
caroticocarotid bypass was performed with PTFE
graft (8 mm, 80 cm. Perouse, PFTR0880). via bilat-
eral femoral incisions under general anesthesia,
new endovascular graft (40X40, 200 mm, Medtron-
ics TF4040C200X) was placed as the new PLZ be-
tween truncus brachiocephalicus (TB) and LCA
(Fig. 2) No additional procedure was performed
for LSA as there were no symptoms in left upper
extremity.
The operation and the postoperative follow-up
were uneventful. The patient was discharged on
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control contrasted CT was seen (Fig. 3).C
A
SDiscussion
As new techniques and methods have devel-
oped, mortality rates have decreased to 2–3% in
open surgery but in older and high risk patients,
mortality rates still remain high in thoracic aortic
aneurysms [1]. Open surgery was the first choice
in the past but with developing technologies,
endovascular approaches became superior to
open surgery. TEVAR is the safer and effective
treatment method in the proper and selected pa-
tients especially with descending TAA [2]. As the
indications for TEVAR are almost the same [4]
with open surgery, TEVAR has become the
first choice of treatment because of low mortality
and morbidity rates compared with open surgery
[3–7].
Moreover, limitations of both open surgery and
TEVAR begin with the aortic arc involvement.
Freezor et al. [8] reported LSA involvement as
over 40% for the patients who had undergone
TEVAR for TAA. Reports have shown that in-pa-
tients who had undergone TEVAR and LSA cov-
erage, the incidence of arm, spinal cord and
vertebrobasilar ischemia is 6%, 4% and 2%,
respectively. These patients also have 5% risk
for anterior circulation stroke and 6% for death
[8]. Despite these adverse outcomes, some practi-
tioners agree to perform LSA revascularization in
some situations, particularly when there is a
dominant left vertebral artery (60%), a previous
left internal mammary coronary artery bypass
graft or when the distal right vertebral segment
is absent [9]. When LCA and TB are both in-
cluded in aneurysms, hybrid procedures (TEVAR
+ complementary surgeries) come into consider-
ation [3,10]. Hughes et al. [10] performed proxi-
mal ascending aorta based debranching with
TEVAR in 12 patients with an adequate PLZ in
ascending aorta, caroticocarotid bypass with TE-
VAR in twelve patients with adequate PLZ be-
tween TB and LCA. Johnston et al. [11] have
reported that staged hybrid approach for exten-
sive TAAs combining proximal TEVAR with open
distal TAA repair is safe and appears to be an
effective alternative to traditional open repair
and may decrease morbidity. Both Johnston and
Hughes reported technical success at 100% and
mortality at 0%.
When the aortic wall loses unity (aortic
dissection or an external injury), TEVAR’s late
complications are more frequent. Four open re-
interventions were needed in Fernandez et al. 20patients’ series of aortic injury [6] Fernandez
et al. also reported a lack of proximal device-wall
apposition in eight patients (40%), intragraft mur-
al thrombus formation during the first six months
in seven patients (35%), and an asymptomatic
fracture of the longitudinal reinforcing bar of the
stent graft four years later in one patient (5%).
Similarly, Beregi et al. [12] reported that the use
of endografts in aortic dissection differs from that
of degenerative aneurysm in that the expanding
stent may perforate the dissecting flap, causing
re-entry of flow, and enabling the false lumen dis-
tal from the stent graft to remain patent. No or
incomplete thrombosis of the false lumen was ob-
served in 14% of patients with aortic dissection in
this study. Leurs et al. [13] published a 443-case
series of TEVAR, reporting endoleak and second-
ary intervention rates as 4.2% and 5.2% (respec-
tively) for the aortic aneurysm group and 1.5%
and 1.5% (respectively) for the aortic dissection
group.
It can be said that TEVAR is superior in selected
cases and emergency situations where mortality
and morbidity rates are higher in open surgery.
But it should be kept in mind that TEVAR is fre-
quently compelling for surgeons in late interven-
tions. It would be the third approach for the
same anatomical site and PLZ would be between
LCA and TB in our case. We did not perform a
complementary operation for the left arm in the
first session five years ago as the patient had no
complaint in the five years we did not revascula-
rise the left arm in this third approach. But to
achieve the adequate flow of the brain, we per-
formed right to left caroticocarotid bypass. We be-
lieve that in TAAs that involve LCA and LSA,
closure of the native orifices with endovascular
grafts and performing extra-anatomic bypasses
(especially for carotid artery) would be a better
way either to prevent type 1 proximal leaks or to
achieve enough blood flow of the brain. In this
method, LCA must be bypassed extra-anatomi-
cally in the same session with TEVAR, but LSA
may be followed and shall be bypassed if left
arm symptoms occur.References
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